首页> 中文期刊> 《黑龙江医药》 >基于BCS系统Ⅳ类药物提高口服生物利用度的研究进展

基于BCS系统Ⅳ类药物提高口服生物利用度的研究进展

         

摘要

目的:综述BCS-Ⅳ类药物提高口服生物利用度的方法。方法:阅读有关该类药物中外文献综合阐述。结果:BCS-Ⅳ类药物可以通过提高溶出速率、增加生物膜通透性,并从同时增加溶出速率和生物膜通透性等途径提高生物利用度。结论:BCS-Ⅳ类药物的溶出速率慢,生物利用度低的问题已经通过新技术、新剂型得到良好的解决,为BCS-Ⅳ类药物的研究及应用提供基础。%Objective:To review the method of improve the oral bioavailability of BCS-IV drugs. Methods:By reviewing the re-lated literature at domestic and abroad to comprehensively expound. Results:BCS-IV drugs can improve the bioavailability by ways such as increase dissolution rate and biological membrane permeability, at the same time increase both of the dissolution rate and membrane permeability. Conclusion:The problem of BCS-IV drug has been solved successfully by the new dosage forms and new technology that provide the basis for the further study and application to BCS-IV drugs.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号